KLOW (GHK-Cu + BPC-157 + TB-500 + KPV)

American Peptide Co.
$275.00
(No reviews yet)
Current Stock:

What is KLOW (GHK‑Cu + BPC‑157 + TB‑500 + KPV)?

KLOW is a research peptide blend combining GHK‑Cu, BPC‑157, TB‑500, and the anti‑inflammatory tripeptide KPV. Each component has distinct signaling roles: GHK‑Cu supports collagen synthesis and tissue remodeling, BPC‑157 influences tendon, ligament, and muscle repair, TB‑500 promotes cell migration and angiogenesis, and KPV helps modulate inflammatory pathways. Together, the blend targets multiple biological pathways involved in tissue recovery, structural resilience, and inflammatory regulation.

What it does / research shows

Preclinical research suggests that combining these peptides may provide complementary effects: enhanced connective tissue repair, improved vascularization, extracellular matrix stabilization, and inflammation modulation. Studies indicate multi-component signaling can be more effective in complex tissue recovery than single peptides alone.

Why motorcycle racers might find it interesting

Riders frequently experience injuries, tissue stress, and repetitive strain. Research suggests KLOW may support accelerated recovery, maintain connective tissue resilience, help manage inflammatory responses, and aid injury recovery.

Form & Use

Sold as a powder. To be reconstituted with bacteriostatic water before subcutaneous injection.

Disclaimer

Sold for research purposes only. Not FDA‑approved for therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease or condition. Always consult a qualified healthcare professional before use. Contact us for consultation and purchase.